Skip navigation
logo
(AFX UK Focus) 2009-08-26 21:50
BRIEF-Alkermes: firms not pursuing risperidone
Article layout: raw

Aug 26 (Reuters) - Alkermes Inc, in filing with the SEC:

  • SAYS JOHNSON & JOHNSON AND CILAG INTERNATIONAL NOT TO PURSUE development of four-week long-acting injectable formulation of risperidone

  • SAYS DECISION BASED ON REVIEW BY J&J'S ORTHO-MCNEIL-JANSSEN AND CILAG'S
    Janssen Pharmaceutica International

    ((New York Equities Desk; tel: +1 646 223 6000)) (For more news about Alkermes Inc click here:)

    COPYRIGHT

    Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.

  • Re-organisations, re-structurings, name changes, AGM, EGM
    Article layout: raw
    Jump back to site navigation